Edwards Lifesciences (EW) Competitors

Edwards Lifesciences logo
$76.22 +0.23 (+0.30%)
Closing price 02/14/2025 03:59 PM Eastern
Extended Trading
$76.12 -0.10 (-0.13%)
As of 02/14/2025 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EW vs. BSX, SYK, MDT, BDX, IDXX, RMD, DXCM, STE, PODD, and BAX

Should you be buying Edwards Lifesciences stock or one of its competitors? The main competitors of Edwards Lifesciences include Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), and Baxter International (BAX). These companies are all part of the "health care equipment" industry.

Edwards Lifesciences vs.

Boston Scientific (NYSE:BSX) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Boston Scientific presently has a consensus price target of $107.39, indicating a potential upside of 1.13%. Edwards Lifesciences has a consensus price target of $79.95, indicating a potential upside of 4.89%. Given Edwards Lifesciences' higher possible upside, analysts clearly believe Edwards Lifesciences is more favorable than Boston Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Boston Scientific
0 Sell rating(s)
1 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
3.00
Edwards Lifesciences
1 Sell rating(s)
13 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.42

Edwards Lifesciences received 282 more outperform votes than Boston Scientific when rated by MarketBeat users. Likewise, 70.85% of users gave Edwards Lifesciences an outperform vote while only 69.87% of users gave Boston Scientific an outperform vote.

CompanyUnderperformOutperform
Boston ScientificOutperform Votes
1055
69.87%
Underperform Votes
455
30.13%
Edwards LifesciencesOutperform Votes
1337
70.85%
Underperform Votes
550
29.15%

Boston Scientific has higher revenue and earnings than Edwards Lifesciences. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Boston Scientific$16.75B9.35$1.59B$1.2584.96
Edwards Lifesciences$6.00B7.49$1.40B$6.9311.00

In the previous week, Edwards Lifesciences had 30 more articles in the media than Boston Scientific. MarketBeat recorded 87 mentions for Edwards Lifesciences and 57 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 0.92 beat Edwards Lifesciences' score of 0.69 indicating that Boston Scientific is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Boston Scientific
36 Very Positive mention(s)
2 Positive mention(s)
13 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Edwards Lifesciences
36 Very Positive mention(s)
10 Positive mention(s)
18 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 0.5% of Boston Scientific shares are owned by insiders. Comparatively, 1.3% of Edwards Lifesciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Edwards Lifesciences has a net margin of 70.82% compared to Boston Scientific's net margin of 11.07%. Edwards Lifesciences' return on equity of 20.76% beat Boston Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Boston Scientific11.07% 18.11% 9.99%
Edwards Lifesciences 70.82%20.76%15.27%

Boston Scientific has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500.

Summary

Edwards Lifesciences beats Boston Scientific on 10 of the 19 factors compared between the two stocks.

Get Edwards Lifesciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EW vs. The Competition

MetricEdwards LifesciencesSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$44.96B$10.19B$5.87B$20.39B
Dividend YieldN/A1.39%5.27%3.67%
P/E Ratio11.0011.6816.4438.17
Price / Sales7.4939.63467.0616.46
Price / Cash25.6919.5846.0620.33
Price / Book6.885.737.275.73
Net Income$1.40B$198.18M$3.19B$1.00B
7 Day Performance7.28%3.40%1.67%0.13%
1 Month Performance9.25%3.12%4.11%1.37%
1 Year Performance-11.47%-12.30%22.09%16.03%

Edwards Lifesciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EW
Edwards Lifesciences
4.1112 of 5 stars
$76.23
+0.3%
$79.95
+4.9%
-11.5%$44.96B$6.00B11.0019,800Earnings Report
Insider Trade
Short Interest ↑
Analyst Revision
BSX
Boston Scientific
4.589 of 5 stars
$106.25
+0.9%
$107.39
+1.1%
+61.3%$156.55B$16.75B84.9848,000Short Interest ↓
SYK
Stryker
4.8311 of 5 stars
$392.13
+0.2%
$420.68
+7.3%
+10.2%$149.52B$22.60B50.5452,000Positive News
MDT
Medtronic
4.5186 of 5 stars
$90.82
+0.9%
$95.00
+4.6%
+10.2%$116.49B$32.36B27.7895,000Upcoming Earnings
Positive News
BDX
Becton, Dickinson and Company
4.9302 of 5 stars
$229.21
-0.3%
$283.00
+23.5%
-6.6%$66.55B$20.18B38.1274,000Analyst Forecast
Short Interest ↓
Positive News
IDXX
IDEXX Laboratories
4.6036 of 5 stars
$464.63
+1.1%
$533.75
+14.9%
-20.0%$38.05B$3.90B43.5511,000
RMD
ResMed
4.409 of 5 stars
$237.36
+0.2%
$244.73
+3.1%
+29.1%$34.94B$4.69B28.099,980Positive News
DXCM
DexCom
4.7955 of 5 stars
$88.03
-0.1%
$98.41
+11.8%
-23.9%$34.39B$3.62B52.739,600Earnings Report
Analyst Forecast
Short Interest ↑
Analyst Revision
Gap Up
STE
STERIS
4.762 of 5 stars
$224.08
+0.4%
$258.75
+15.5%
-5.1%$22.12B$5.14B47.5818,179Positive News
PODD
Insulet
4.5227 of 5 stars
$285.58
+0.9%
$277.13
-3.0%
+46.9%$20.03B$1.70B48.903,000Upcoming Earnings
Positive News
BAX
Baxter International
4.605 of 5 stars
$30.66
+0.1%
$40.90
+33.4%
-25.2%$15.67B$14.81B153.4860,000Dividend Announcement

Related Companies and Tools


This page (NYSE:EW) was last updated on 2/17/2025 by MarketBeat.com Staff
From Our Partners